News

Press ReleaseCell and gene therapy industry continues to expand manufacturing infrastructure in the UK
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Regulatory Round-up - March 2022Regulatory Round-up - March 2022Press release: Symbiosis announces successful completion of UK Research and Innovation (UKRI) projectPress release: Symbiosis announces successful completion of UK Research and Innovation (UKRI) projectPress release: Cell And Gene Therapy Catapult Launches 2021 Clinical Trials Database ReportPress release: Cell And Gene Therapy Catapult Launches 2021 Clinical Trials Database ReportUKRI strategy will keep UK at forefront of research and innovationUKRI strategy will keep UK at forefront of research and innovationRoundtable Report: Past and present experience of ATMP in the UK to inform future best practiceRoundtable Report: Past and present experience of ATMP in the UK to inform future best practiceRegulatory Round-up - February 2022Regulatory Round-up - February 2022Catapult Network confirms commitment to Equality, Diversity and InclusionCatapult Network confirms commitment to Equality, Diversity and InclusionPfizer’s Brian Henry appointed head of UK medicines manufacturing partnershipPfizer’s Brian Henry appointed head of UK medicines manufacturing partnershipRegulatory NewsRegulatory News January 2022Press Release: MICA Biosystems to collaborate with the Cell and Gene Therapy CatapultPress Release: MICA Biosystems to collaborate with the Cell and Gene Therapy CatapultRegulatory News - January 2022Regulatory News - January 2022Catapult Network announces new chair, confirms commitment to supporting delivery of levelling up agendaCatapult Network announces new chair, confirms commitment to supporting delivery of levelling up agenda